Salvia lavandulaefolia (Spanish Sage) enhances memory in healthy young volunteers

Pharmacology Biochemistry and Behavior

Volumn 75, Issue 3, 2003, Pages 669-674

  Tildesley, N T J ^a   Kennedy, D O ^a   Perry, E K ^b   Ballard, C G ^b   Savelev, S ^c   Wesnes, K A ^a,d   Scholey, A B ^a  

^a NORTHUMBRIA UNIVERSITY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d Newcastle University ^*  (United Kingdom)

Author keywords

Acute effects; Cholinergic; Memory; Sage; Salvia

Indexed keywords

ESSENTIAL OIL; PLANT EXTRACT; SALVIA LAVANDULAEFOLIA EXTRACT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; FEMALE; HUMAN; MALE; MEMORY; NORMAL HUMAN; PRIORITY JOURNAL; RECALL; SALVIA; SALVIA LAVANDULAEFOLIA; TREATMENT OUTCOME; VERBAL MEMORY; WORD RECOGNITION;

SALVIA; SALVIA HISPANICA; SALVIA LAVANDULAEFOLIA; SALVIA LAVANDULIFOLIA;

EID: 0041853692     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(03)00122-9     Document Type: Article

References (47)

1. Almkvist O., Jelic V., Amberla K., Hellstrom-Lindahl E., Meurling L., Nordberg A. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients. Dement. Geriatr. Cogn. Disord. 12:2001;22-32.
2. Bartram T. Bartram's encyclopedia of herbal medicine. 1998;Robinson, London.
3. Birge J.D. The role of oestrogen in the treatment and prevention of dementia. Am. J. Med. 103:1997;1-50.
4. Caso Marasco A., Vargas Ruiz R., Salas Villagomez A., Begona Infante C. Double-blind study of a multivitamin complex supplemented with ginseng extract. Drugs Exp. Clin. Res. 22:1996;323-329.
5. Cho H.-M., Song D.-K., Suh H.-W., Kim Y.-H. Serotonin uptake blocking activity from herb medicines. Neuropsychopharmacology. 10:1994;137.
6. Chung I.-W., Chen G., Manji H., Kim Y.-S., Ahn J.-S., Potter W.Z.et al. Binding of natural medicinal products to alpha 2 adrenergic receptors. Neuropsychopharmacology. 10:1994;137.
7. D'Angelo L., Grimaldi R., Caravaggi M., Marcoli M., Perucca E., Lecchini S.et al. A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers. J. Ethnopharmacol. 16:1986;15-22.
8. Dhawan B.N. Development of CNS active agents from plants. Neuropsychopharmacology. 10:1994;689.
9. Duke J.A. CRC handbook of medicinal herbs. 1985;420-421 CRC Press, United States.
10. Ebert U., Siepmann M., Oertel R., Wesnes K., Kirch W. Pharmacokinetics and pharmacodynamics of scopolamine after subcutaneous administration. J. Clin. Pharmacol. 38:1998;720-726.
11. Fournier G., Pages N., Cosperec I. Contribution to the study of Salvia lavandulaefolia essential oil: potential toxicity attributable to sabinyl acetate. Planta Med. 59:1993;96-97.
12. Hill J. The family herbal. 1755;. London.
13. Jackson B.D. A catalogue of plants. 1876;1596-1599. London.
14. Kennedy D.O., Scholey A.B., Wesnes K.A. The dose dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology. 151:2000;416-423.
15. Kennedy D.O., Scholey A.B., Wesnes K.A. Differential, dose-dependent changes in cognitive performance and mood following acute administration of Ginseng to healthy young volunteers. Nutr. Neurosci. 4:2001;295-310.
16. Kennedy D.O., Scholey A.B., Wesnes K.A. Differential, dose dependent changes in cognitive performance following acute administration of a Ginkgo biloba/Panax ginseng combination to healthy young volunteers. Nutr. Neurosci. 4:2001;399-412.
17. Kennedy D.O., Scholey A.B., Wesnes K.A. Modulation of cognition and mood following administration of single doses of Ginkgo biloba, Ginseng and a Ginkgo/Ginseng combination to healthy young adults. Physiol. Behav. 75:2002;1-13.
18. Kennedy D.O., Scholey A.B., Tildesley N.T.J., Perry E.K., Wesnes K.A. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon Balm). Pharmacol. Biochem. Behav. 72:2002;953-964.
19. Kennedy D.O., Wake G., Savelev S., Tildesley N.T.J., Perry E.K., Wesnes K.A.et al. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor binding properties. Neuropsychopharmacology. 2003;. [in press].
20. Keppel G. Design and analysis. 1991;Prentice-Hall, New Jersey.
21. Le Bars P.L., Katz M.M., Berman N., Itil T.M., Freedman A.M., Schatzberg A.F. A placebo controlled, double blind, randomised trial of an extract of Ginkgo biloba for dementia. North American EGb study group. J. Am. Med. Assoc. 278:1997;1327-1332.
22. Leung A.Y., Foster S. Encyclopaedia of common natural ingredients. 1996;Wiley, Chichester.
23. Mantle D., Pickering A.T., Perry E.K. Medicinal plant extracts for the treatment of dementia: a review of their pharmacology, efficacy and tolerability. CNS Drugs. 13:2000;201-213.
24. Moss M.C., Scholey A.B., Wesnes K. Oxygen administration selectively enhances cognitive performance in healthy young adults: a placebo-controlled double blind crossover study. Psychopharmacology. 138:1998;27-33.
25. Okugawa H., Ueda R., Matsumoto K., Kawanishi K., Kato A. Effect of dehydrocostus lactone and costunolide from saussurea root on the central nervous system in mice. Phytomedicine. 3:1996;147-153.
26. O'Neill W.M., Hanks G.W., White L., Simpson P., Wesnes K. The cognitive and psychomotor effects of opioid analgesics: I. A randomised controlled trial of single doses of dextropropoxyphrene, lorazepam and placebo in healthy subjects. Eur. J. Clin. Pharmacol. 48:1995;447-453.
27. Pages N., Fournier G., Velut V., Imbert C. Potential teratogenicity in mice of the essential oil of Salvia lavandulaefolia Vahl. Study of a fraction rich in sabinyl acetate. Phytother. Res. 6:1992;80-83.
28. Perry N., Court G., Bidet N., Court J., Perry E. European herbs with cholinergic activities: potential in dementia therapy. Int. J. Geriatr. Psychiatry. 11:1996;1063-1069.
29. Perry N., Houghton P.J., Jenner P. Inhibition of erythrocyte acetylcholinesterase by droplet counter-current chromatography fractions of Salvia lavandulaefolia oil. J. Pharm. Pharmacol. 49:1997;34.
30. Perry E.K., Pickering A.T., Wang W.W., Houghton P.J., Perry N.S.L. Medicinal plants and Alzheimer's disease: from ethnobotany to phytotherapy. J. Pharm. Pharmacol. 51:1999;527-534.
31. Perry N.S.L., Houghton P., Theobald A., Jenner P., Perry E.K. In-vitro inhibition of human erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constituent terpenes. J. Pharm. Pharmacol. 52:2000;895-902.
32. Perry N., Howes M., Houghton P., Perry E. Why Sage may be a wise remedy: effects of Salvia on the nervous system. Kintzios S.E. Sage: the genus Salvia. 2000;Harwood Academic Publishers, Amsterdam.
33. Perry N.S.L., Houghton P.J., Jenner P., Keith A., Perry E.K. Salvia lavandulaefolia essential oil inhibits cholinesterase in vivo. Phytomedicine. 9:2002;48-51.
34. Planchon L., Bretin P. Précis de Matiere Medicale. 1946;1907-1911 Libraire Maloire Paris, France.
35. Raskind M.A., Peskind E.R., Wessel T., Yuan W., Allen F.H., Aronsom S.M.et al. Galanthamine in AD: a 6 month randomised, placebo-controlled trial with a 6 month extension. Neurology. 54:2000;2261-2268.
36. Reynolds J.E.F. The extra pharmacopoeia. 31st ed. 1996;1681-1682 Royal Pharmaceutical Society, Martindale (London).
37. Rusted J.M., Newhouse P.A., Levin E.D. Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer's disease and Parkinson's disease. Behav. Brain Res. 113:2000;121-129.
38. Scholey A.B., Kennedy D.O. Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand. Hum. Psychopharmacol. Clin. Exp. 17:2002;35-44.
39. Scholey A.B., Moss M.C., Neave N., Wesnes K.A. Cognitive performance, hyperoxia and heart rate following oxygen administration in healthy young adults. Physiol. Behav. 67:1999;783-789.
40. Silva I., Mor G., Naftolin F. Estrogen and the aging brain. Maturitas. 38:2001;95-101.
41. Su G.B., Saito N., Kinoshita T., Yagu T., Nobuhara K., Okajima Y.et al. Effect of oriental medicine (TJ-54) on senile dementia. Neuropsychopharmacology. 10:1994;137.
42. Tildesley NTJ, Kennedy DO, Perry EK, Ballard CG, Wesnes KA, Scholey AB. Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia in healthy young volunteers, under review.
43. Tyler V.E. Phytomedicines in Western Europe: potential impact on herbal medicine in the United States. Human medicinal agents from plants. Am. Chem. Soc. 1993;25-37.
44. Wake G., Court J., Pickering A., Lewis R., Wilkins R., Perry E.K. CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. J. Ethnopharmacol. 69:2000;105-114.
45. Wesnes K., Simmons D., Rook M., Simpson P. A double blind placebo controlled trial of Tanakan in the treatment of idiopathic cognitive impairment in the elderly. Hum. Psychopharmacol. Clin. Exp. 2:1987;159-169.
46. Wesnes K.A., Faleni R.A., Hefting N.R., Hoogsteen G., Houben J.J.G., Jenkins E.et al. The cognitive, subjective, and physical effects of a Ginkgo biloba/Panax ginseng combination in healthy volunteers with neurasthenic complaints. Psychopharmacol. Bull. 33:1997;677-683.
47. White H.K., Levin E.D. Four week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. Psychopharmacology. 143:1999;158-165.